Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 2,337 | 2,057 | 1,671 | 1,952 | 1,392 |
| Cost of Goods | 1,518 | 1,153 | 2,446 | 1,147 | 595 |
| Gross Profit | 819 | 904 | -775 | 805 | 797 |
| Operating Expenses | 5,092 | 2,871 | -2,132 | 2,063 | 2,506 |
| Operating Income | -3,755 | -1,814 | 1,803 | -1,111 | -1,114 |
| Interest Expense | 22 | 63 | 87 | 23 | 24 |
| Other Income | 1,881 | 64 | 252 | 146 | 43 |
| Pre-tax Income | -1,896 | -1,813 | 1,968 | -988 | -1,095 |
| Income Tax | -474 | -412 | -438 | -212 | -235 |
| Net Income Continuous | -1,422 | -1,401 | 2,406 | -776 | -860 |
| Net Income | $-1,422 | $-1,401 | $2,406 | $-776 | $-860 |
| EPS Basic Total Ops | -0.64 | -0.76 | 2.51 | -0.42 | -0.47 |
| EPS Basic Continuous Ops | -0.64 | -0.76 | 2.50 | -0.42 | -0.47 |
| EPS Diluted Total Ops | -0.64 | -0.76 | 2.51 | -0.42 | -0.47 |
| EPS Diluted Continuous Ops | -0.64 | -0.76 | 2.50 | -0.42 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -4.74 | -4.64 | N/A | N/A |
| EBITDA(a) | $-3,378 | $-1,455 | $2,162 | $-748 | $327 |